欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/4968/001
药品名称
Abiraterone 250 mg
活性成分
abiraterone acetate 250.0 mg
剂型
Tablet
上市许可持有人
Genthon BV, Netherlands
参考成员国 - 产品名称
Netherlands (NL)
Abiraterone Genthon 250 mg, tabletten
互认成员国 - 产品名称
Spain (ES)
Portugal (PT)
Italy (IT)
Sweden (SE)
Poland (PL)
Abiraterone Genthon
Belgium (BE)
Abirateron Fresenius Kabi 250 mg tabletten/comprimés/Tabletten
United Kingdom (Northern Ireland) (XI)
Austria (AT)
Abirateron Fresenius Kabi 250 mg Tabletten
许可日期
2021/03/10
最近更新日期
2023/12/04
药物ATC编码
L02BX03 abiraterone
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Multiple (Copy) Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PAR Summary
|
summaryPAR_4968 Abirateron Fresenius Kabi_4 aug_EN
Date of last change:2021/09/20
PAR
|
PAR_4968_Abirateron Fresenius Kabi_4 aug
Date of last change:2021/09/20
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase